Lynx Equity defends AMAT and LRCX stocks amid pressures

Lynx Equity reaffirmed bullish targets on Applied Materials and Lam Research, with AMAT set at $540 and LRCX at $325, despite recent negative sentiment. Applied Materials also drew multiple price-target increases from Wall Street, including Cantor Fitzgerald at $575, Needham at $530, and TD Cowen at $525, after strong results and raised 2026 guidance showing Semi Systems revenue growth above 30%. The article highlights favorable multi-year wafer fab equipment cycle expectations into 2028-2029, supporting a constructive view on the semiconductor equipment group.

Analysis

The key second-order effect is not just that AMAT/LRCX are beneficiaries of a healthier WFE cycle; it is that their improving visibility extends the duration of capex elasticity in the broader AI supply chain. When equipment vendors guide multi-year growth, foundries and memory makers tend to defer aggressive inventory cuts, which supports adjacent winners in process control, wafers, gas, and consumables with less headline risk than the names in this article. In practice, that usually means the market underprices the breadth of the cycle until after a few quarters of sequential beats.

The more interesting setup is asymmetry between fundamentals and positioning. AMAT already screens like a consensus winner, so the easy money is likely in the “less loved but levered” second derivative names, while the main risk is that the market starts discounting 2027-2029 cycle claims too aggressively and rotates into the next bottleneck rather than the current beneficiaries. If DRAM and advanced logic spending stays firm, the upside is a long-duration earnings compounding story; if AI capex normalizes, these names can de-rate quickly because the multiple already embeds a lot of cycle durability.

For the broader tape, this is mildly disinflationary for semiconductor volatility: equipment strength often precedes a wave of supply additions that eventually caps margins in the more crowded end markets. That creates a tactical window where long-quality equipment can still work, but the cleaner expression may be relative value rather than outright beta. The contrarian miss is that consensus is already comfortable with AMAT; the better trade may be to own the providers of the picks-and-shovels to the picks-and-shovels, or to fade crowded optimism if guidance fails to accelerate further over the next 1-2 prints.

Key Decisions for Investors

• Long AMAT into the next 1-2 earnings cycles, but size as a quality compounder rather than a momentum trade; upside remains, but the risk/reward is now more about steady estimate revisions than multiple expansion.
• Prefer LRCX over AMAT on a 6-12 month horizon if you want a higher beta expression to NAND/WFE recovery; use pullbacks to build, with the thesis invalidated if memory capex commentary turns cautious.
• Pair trade: long semiconductor equipment basket (AMAT, LRCX) / short higher-volatility semi beta or broad SOX exposure for the next 3-6 months; the goal is to isolate cycle durability while reducing tape risk.
• Add a levered satellite long in supply-chain beneficiaries not mentioned here over 2-4 quarters, especially process-control or consumables names, because they often lag the capex signal by one reporting season.
• If AMAT gaps higher on further analyst upgrades, consider selling upside calls 1-2 quarters out to monetize already-rich sentiment; the main near-term risk is valuation compression if guidance merely confirms rather than accelerates.